|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Properties of the permeability transition in VDAC1-/- mitochondria显示文摘 | Kranskopf A Eriksson O Craigen WJ | 2006 | Biochim Biophys Acta2006，1757，： | 1 |
| 2 | Mitochondrial DNA mutations: an overview of clinical and molecular aspects显示文摘 | Craigen WJ | 2012 | Methods Mol Biol2012，837，5： | 1 |
| 3 | Properties of the permeability transition inVDAC1 mitochondria显示文摘 | Krauskopf A Eriksson O Craigen WJ | 2006 | Biochim Biophys Acta2006，1757，56： | 1 |
| 4 | VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAk to the mitochondria 显示文摘 | Roy SS Ehrlich AM Craigen WJ | 2009 | EMBO Rep2009，10，12： | 1 |
| 5 | Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency显示文摘 | Hong YS Kerr DS Craigen WJ | 1996 | Hum Mol Genet1996，5，12： | 1 |
| 6 | Reduced VDAC1 protects against Alzheimer’s disease,mitochondria and synaptic deficiencies显示文摘 | Manczak M Sheiko T Craigen WJ | 2013 | Alzheimer’s Disease2013，37，4： | 1 |
| 7 | Serum leptin level is a regulator of bone mass显示文摘 | Elefteriou F Takeda S Ebihara K Magre J Patano N Kim CA Ogawa Y Liu X Ware SM Craigen WJ Robert JJ Vinson C Nakao K Capeau J Karsenty G | | 0，，： | 1 |
| 8 | Partial COL1A2 gene duplication produces features of osteogenesis imperfecta and Ehlers-Danlos syndrome type Ⅶ显示文摘 | Craigen WJ Smith LT | 2000 | Hum Genet2000，106，： | 1 |
| 9 | Clinical Spectrum, morbidity,and mortality in 113 pediatric patients with mtochondrial disease 显示文摘 | Scag]ia F Towbin JA Craigen WJ | 2004 | Pediatrics2004，114，4： | 1 |
| 10 | Reduced VDAC1 protects against Alzheimer’s disease,mitochondria,and synaptic deficiencies显示文摘 | Manczak M Sheiko T Craigen WJ | 2013 | Alzheimers Disease2013，37，4： | 1 |
| 11 | Properties of the permeability transition in VDAC1 (-/-)mitochondria显示文摘 | Krauskopf A Eriksson O Craigen WJ | 2006 | Biochim Biophys Acta2006，1757，56： | 1 |
| 12 | VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria显示文摘 | Roy SS Ehrlich AM Craigen WJ | | 0，，12： | 1 |
| 13 | Clinical spectrum, morbidity,and mortality in 113 pediatric patients with mito- chondrial disease 显示文摘 | Scaglia F Towbin JA Craigen WJ | 2004 | Pediatrics2004，114，4： | 1 |
| 14 | Properties of the permeability transition in VDAC1 ( -/- ) mitochondria 显示文摘 | Krauskopf A Eriksson O Craigen WJ | 2006 | Biochim Biophys Acta2006，1757，： | 1 |
| 15 | VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria显示文摘 | Roy SS Ehrlich AM Craigen WJ | | 0，，12： | 1 |
| 16 | Postpartum coma and death due to carbamoyl-phosphate synthetase I deficiency 显示文摘 | Wang LJ Craigen WJ O'Brien WE | 1994 | Ann Intern Med1994，120，： | 1 |
| 17 | Mitochondrial regulation of synaptic plasticity in the hippocampus显示文摘 | Levy M Faas GC Saggau P Craigen WJ Sweatt JD | 2003 | J Biol Chem2003，278，17： | 1 |
| 18 | Clinical spectrum,morbidity,and mortality in 113 pediatric patients with mitochondrial disease 显示文摘 | Scaglia F Towbin JA Craigen WJ | 2004 | Pediatrics2004，114，4： | 1 |
| 19 | Properties of the permeability transition in VDAC1(-/-) mitochondria显示文摘 | Krauskopf A Eriksson O Craigen WJ | 2006 | Biochim Biophys Acta2006，1757，56： | 1 |
| 20 | Clinical spectrum morbidity, and mortality in 113 pediatric patients with mitochondrial disease显示文摘 | Scaglia F Towbin JA Craigen WJ | 2004 | Pediatrics2004，114，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员